stockrowThe Clorox Company
CLX Consumer Defensive Household & Personal Products
The Clorox Company’s revenue for fiscal 2026 (year ended June 2026) was $6.7 billion, down 5.41% from fiscal 2025.
- Revenue
- +33.3%
- EPS
- +118.9%
- Free cash flow
- +84.2%
- Total debt
- +60.3%
Quarter to September 2026, against a year earlier
Follow CLX
Alert me
The Clorox Company (CLX) Revenue
The Clorox Company's revenue for fiscal 2026 was $6.7B, down 5.41% from $7.1B in fiscal 2025. Over the twelve months to 30 September 2026 it was $7.2B. Over the past ten years it has ranged from $5.7B (fiscal 2015) to $7.4B (fiscal 2023); the current reading is higher than 50% of that period. The Clorox Company ranks 7th of 27 Household & Personal Products companies by revenue.
Revenue, annual
Embed this chart
Annual newest first
| Period | Revenue | Change |
|---|---|---|
| FY2026 | $6.7B | (5.41%) |
| FY2025 | $7.1B | 0.16% |
| FY2024 | $7.1B | (4.01%) |
| FY2023 | $7.4B | 3.97% |
| FY2022 | $7.1B | (3.19%) |
| FY2021 | $7.3B | 9.22% |
| FY2020 | $6.7B | 8.16% |
| FY2019 | $6.2B | 1.47% |
| FY2018 | $6.1B | 2.53% |
| FY2017 | $6.0B | 3.68% |
Quarterly newest first
| Period | Revenue | Change |
|---|---|---|
| Sep 2026 | $1.9B | (2.21%) |
| Jun 2026 | $1.9B | 16.65% |
| Mar 2026 | $1.7B | (0.18%) |
| Dec 2025 | $1.7B | 17.07% |
| 43 more quarters | Free account |
Against its own ten years
Revenue against peers
| Company | Revenue |
|---|---|
| KMB Kimberly-Clark Corporation compare | $16.6B |
| EL The Estee Lauder Companies Inc. compare | $15.3B |
| NWL Newell Brands Inc. compare | $7.3B |
| CLX The Clorox Company | $7.2B |
| CHD Church & Dwight Co., Inc. compare | $6.2B |
| COTY Coty compare | $5.8B |
| SPB Spectrum Brands Holdings Inc. compare | $2.9B |
| ELF e.l.f. Beauty compare | $1.9B |
| IPAR Interparfums, Inc. compare | $1.5B |
What Revenue is
Revenue tells an investor how much a company brought in from selling its goods and services over a period, before any costs are taken out.
Reported line item
More on CLX
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement